Singularity Future Technology Ltd. (SGLY): Nasdaq/NYSE listing notice — Singularity Future receives Nasdaq delisting notices for board independence and bid price; terminates COO

Singularity Future Technology Ltd.

Received Nasdaq notice on July 13, 2023, for failing independent director/audit committee rule after Tieliang Liu's resignation; cure period until July 2024 or Jan 2024.
Failed to regain $1 bid price compliance after initial 180-day period ended July 5, 2023; granted second 180-day period until Jan 2, 2024.
Company plans to regain bid price compliance via reverse stock split if necessary.
Terminated COO Shan Jing for cause, effective July 10, 2023.
Nasdaq's second bid price extension conditioned on meeting other listing requirements and company's intent to cure.

item 3.01 item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Shan Jing

Chief Operating Officer

SGLY · Singularity Future Technology Ltd.

Effective: 2023-07-10
Filed: July 14, 2023, 7:59 PM ET

On July 10, 2023, Company terminated the employment of its Chief Operating Officer Shan Jing with cause.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Singularity Future Technology Ltd. received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(4)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: audit committee
Rules: 5605(c)(4)

Exact text from the filing

July 13, 2023, Singularity Future Technology Ltd. (the “Company” or the “Registrant”) received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company no longer complies with Nasdaq’s independent director and audit committee requirements under Nasdaq’s Listing Rule 5605 following the resignation of Tieliang Liu from the Company’s board of directors and audit committee effective July 3, 2023. Nasdaq advised the Company that in accordance with Nasdaq’s Listing Rule 5605(c)(4), the Company has a cure period to regain compliance (1) until the earlier of the Company’s next ann

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Singularity Future Technology Ltd. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5605(c)(4), 5605).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5605(c)(4), 5605

Exact text from the filing

July 13, 2023, Singularity Future Technology Ltd. (the “Company” or the “Registrant”) received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company no longer complies with Nasdaq’s independent director and audit committee requirements under Nasdaq’s Listing Rule 5605 following the resignation of Tieliang Liu from the Company’s board of directors and audit committee effective July 3, 2023. Nasdaq advised the Company that in accordance with Nasdaq’s Listing Rule 5605(c)(4), the Company has a cure period to regain compliance (1) until the earlier of the Company’s next ann

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Shan Jing was terminated as Chief Operating Officer at Singularity Future Technology Ltd..

Action: terminated
Role: Chief Operating Officer

Exact text from the filing

On July 10, 2023, Company terminated the employment of its Chief Operating Officer Shan Jing with cause.

View on SEC.gov

18 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Singularity Future Technology Ltd. filing history →

Source: SEC EDGAR

accession 0001213900-23-057078

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.